{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:13:16Z","timestamp":1794535996274,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01631-4","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T09:50:53Z","timestamp":1741341053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Predictive value of preoperative systemic immune-inflammation index and prognostic nutrition index in patients with epithelial ovarian cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Jingping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"1631_CR1","doi-asserted-by":"publisher","first-page":"216057","DOI":"10.1016\/j.canlet.2023.216057","volume":"555","author":"RL Hollis","year":"2023","unstructured":"Hollis RL. Molecular characteristics and clinical behaviour of epithelial ovarian cancers[J]. Cancer Lett. 2023;555:216057. https:\/\/doi.org\/10.1016\/j.canlet.2023.216057.","journal-title":"Cancer Lett"},{"key":"1631_CR2","doi-asserted-by":"publisher","unstructured":"Li J, Lu J, Xu M, et al. ODF2L acts as a synthetic lethal partner with WEE1 inhibition in epithelial ovarian cancer models. Journal of Clinical Investigation. 2023;13 3(2):e161544.https:\/\/doi.org\/10.1172\/JCI161544","DOI":"10.1172\/JCI161544"},{"issue":"8","key":"1631_CR3","doi-asserted-by":"publisher","first-page":"a038216","DOI":"10.1101\/cshperspect.a038216","volume":"13","author":"TA Sellers","year":"2023","unstructured":"Sellers TA, Peres LC, Hathaway CA, et al. Prevention of Epithelial Ovarian Can cer[J]. Cold Spring Harb Perspect Med. 2023;13(8):a038216. https:\/\/doi.org\/10.1101\/cshperspect.a038216.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1631_CR4","doi-asserted-by":"publisher","unstructured":"Gaitskell K, Rogozi\u0144ska E, Platt S, et al. Angiogenesis inhibitors for the treatment of epithelial ovarian cancer[J]. Cochrane Database of Systematic Reviews. 2023;2023(4):CD007930. https:\/\/doi.org\/10.1002\/14651858.CD007930.pub3","DOI":"10.1002\/14651858.CD007930.pub3"},{"key":"1631_CR5","doi-asserted-by":"publisher","unstructured":"Zachou G, El-Khouly F, Dilley J. Evaluation of follow-up strategies for women with epitheli al ovarian cancer following completion of primary treatment[J]. Cochrane Database of Systematic Reviews. 2023;2023(8):CD006119. https:\/\/doi.org\/10.1002\/14651858.CD006119.pub4","DOI":"10.1002\/14651858.CD006119.pub4"},{"issue":"37","key":"1631_CR6","doi-asserted-by":"publisher","first-page":"e35240","DOI":"10.1097\/MD.0000000000035240","volume":"102","author":"L Song","year":"2023","unstructured":"Song L, Qi J, Zhao J, et al. Diagnostic value of CA125, HE4, and systemic immune-inflammation index in the preoperative investigation of ovarian masses[J]. Medicine. 2023;102(37):e35240. https:\/\/doi.org\/10.1097\/MD.0000000000035240.","journal-title":"Medicine"},{"issue":"2","key":"1631_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ygyno.2018.11.034","volume":"152","author":"D Nie","year":"2019","unstructured":"Nie D, Gong H, Mao X, et al. Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study[J]. Gynecol Oncol. 2019;152(2):259\u201364. https:\/\/doi.org\/10.1016\/j.ygyno.2018.11.034.","journal-title":"Gynecol Oncol"},{"issue":"14","key":"1631_CR8","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.3390\/cancers15143607","volume":"15","author":"M Mleko","year":"2023","unstructured":"Mleko M, Pluta E, Pitynski K, et al. Trends in Systemic Inflammatory Reaction (SIR) during Paclitaxel and Carboplatin Chemotherapy in Women Suffering from Epithelial Ovarian Cancer[J]. Cancers. 2023;15(14):3607. https:\/\/doi.org\/10.3390\/cancers15143607.","journal-title":"Cancers"},{"key":"1631_CR9","doi-asserted-by":"publisher","unstructured":"Mleko M, Pitynski K, Pluta E, et al. Role of Systemic Inflammatory Reaction in Fe male Genital Organ Malignancies\u2013State of the Art[J]. Cancer Management and Research. 2021;Volume13:5491\u20135508. https:\/\/doi.org\/10.3390\/cancers15143607","DOI":"10.3390\/cancers15143607"},{"issue":"3","key":"1631_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.amjsurg.2011.10.015","volume":"204","author":"S Dutta","year":"2012","unstructured":"Dutta S, Crumley ABC, Fullarton GM, et al. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer[J]. The American Journal of Surgery. 2012;204(3):294\u20139. https:\/\/doi.org\/10.1016\/j.amjsurg.2011.10.015.","journal-title":"The American Journal of Surgery"},{"issue":"12","key":"1631_CR11","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1111\/cas.15964","volume":"114","author":"Q Huai","year":"2023","unstructured":"Huai Q, Luo C, Song P, et al. Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non-small cell lung cancer patients with neoadjuvant immunotherapy[J]. Cancer Sci. 2023;114(12):4484\u201398. https:\/\/doi.org\/10.1111\/cas.15964.","journal-title":"Cancer Sci"},{"issue":"1","key":"1631_CR12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1186\/s12885-018-4732-8","volume":"1","author":"Z Feng","year":"2018","unstructured":"Feng Z, Wen H, Ju X, et al. The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer[J]. BMC Cancer. 2018;1(1):883. https:\/\/doi.org\/10.1186\/s12885-018-4732-8.","journal-title":"BMC Cancer"},{"issue":"11","key":"1631_CR13","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1159\/000452263","volume":"39","author":"Y Miao","year":"2016","unstructured":"Miao Y, Li S, Yan Q, et al. Prognostic Significance of Preoperative Prognostic Nutritional Index in Epithelial Ovarian Cancer Patients Treated with Platinum-Based Chemotherapy[J]. Oncology Research and Treatment. 2016;39(11):712\u20139. https:\/\/doi.org\/10.1159\/000452263.","journal-title":"Oncology Research and Treatment"},{"issue":"1","key":"1631_CR14","doi-asserted-by":"publisher","first-page":"9548","DOI":"10.1038\/s41598-017-10328-8","volume":"7","author":"W Zhang","year":"2017","unstructured":"Zhang W, Ye B, Liang W, et al. Preoperative prognostic nutritional index is a powerful predictor of prognosis in patients with stage III ovarian cancer[J]. Sci Rep. 2017;7(1):9548. https:\/\/doi.org\/10.1038\/s41598-017-10328-8.","journal-title":"Sci Rep"},{"issue":"2","key":"1631_CR15","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/jcp.27052","volume":"234","author":"H Zhang","year":"2018","unstructured":"Zhang H, Shang X, Ren P, et al. The predictive value of a preoperative systemic Immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma[J]. J Cell Physiol. 2018;234(2):1794\u2013802. https:\/\/doi.org\/10.1002\/jcp.27052.","journal-title":"J Cell Physiol"},{"key":"1631_CR16","doi-asserted-by":"publisher","unstructured":"He H, Guo W, Song P, et al. Preoperative systemic immune-inflammation index and prognostic nutritional index predict prognosis of patients with pulmonary neuroendocrine tumors after surgical resection[J]. Annals of Translational Medicine. 2020;8(10):630. https:\/\/doi.org\/10.21037\/atm-19-4476","DOI":"10.21037\/atm-19-4476"},{"key":"1631_CR17","doi-asserted-by":"publisher","unstructured":"Ding P a, Yang P, Sun C, et al. Predictive Effect of Systemic Immune-Inflammation Index Combined With Prognostic Nutrition Index Score on Efficacy and Prognosis of Neoadjuvant Intraperitoneal and Systemic Paclitaxel Combined With Apatinib Conversion Therapy in Gastric Cancer Patients With Positive Peritoneal Lavage Cytology: A Prospective Study[J]. Frontiers in Oncology. 2022;11:791912. https:\/\/doi.org\/10.3389\/fonc.2021.791912","DOI":"10.3389\/fonc.2021.791912"},{"key":"1631_CR18","doi-asserted-by":"publisher","first-page":"1193962","DOI":"10.3389\/fonc.2023.1193962","volume":"13","author":"H Mao","year":"2023","unstructured":"Mao H, Yang F. Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis[J]. Front Oncol. 2023;13:1193962. https:\/\/doi.org\/10.3389\/fonc.2023.1193962.","journal-title":"Front Oncol"},{"issue":"1","key":"1631_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev.immunol.021908.132544","volume":"27","author":"M Dougan","year":"2009","unstructured":"Dougan M, Dranoff G. Immune Therapy for Cancer[J]. Annual Review of Immunol ogy. 2009;27(1):83\u2013117. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132544.","journal-title":"Annual Review of Immunol ogy"},{"key":"1631_CR20","doi-asserted-by":"publisher","unstructured":"Wang J, Liu Y, Mi X, et al. The prognostic value of prognostic nutritional index(PNI) and neutrophil to lymphocyte ratio(NLR) for advanced non-small cell lung cacer treated with platinum-based chemotherapeutics[J]. Annals of Palliative Medicine2 020;9(3):967\u2013978. https:\/\/doi.org\/10.21037\/apm.2020.04.31","DOI":"10.21037\/apm.2020.04.31"},{"issue":"4","key":"1631_CR21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/jso.26757","volume":"125","author":"C Ma","year":"2021","unstructured":"Ma C, Yu R, Li J, et al. Preoperative prognostic nutritional index and systemic immne-inflammation index predict survival outcomes in osteosarcoma: A comparisonbetween young and elderly patients[J]. J Surg Oncol. 2021;125(4):754\u201365. https:\/\/doi.org\/10.1002\/jso.26757.","journal-title":"J Surg Oncol"},{"issue":"1","key":"1631_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13048-023-01106-4","volume":"16","author":"K Huang","year":"2023","unstructured":"Huang K, Xu S, Wang J, et al. Combined use of CA125, neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors[J]. Journal of Ovarian Research. 2023;16(1):37. https:\/\/doi.org\/10.1186\/s13048-023-01106-4.","journal-title":"Journal of Ovarian Research"},{"key":"1631_CR23","doi-asserted-by":"publisher","unstructured":"Zhang C-l, Jiang X-c, Li Y, et al. Independent predictive value of blood inflammatory composite markers in ovarian cancer:recent clinical evidence and perspective focusing on NLR and PLR[J]. Journal of Ovarian Research. 2023;16(1):36. https:\/\/doi.org\/10.1186\/s13048-023-01116-2","DOI":"10.1186\/s13048-023-01116-2"},{"issue":"2","key":"1631_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10555-017-9673-1","volume":"36","author":"MZ Wojtukiewicz","year":"2017","unstructured":"Wojtukiewicz MZ, Sierko E, Hempel D, et al. Platelets and cancer angiogenesis nexu[J]. Cancer Metastasis Rev. 2017;36(2):249\u201362. https:\/\/doi.org\/10.1007\/s10555-017-9673-1.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"1631_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/CBM-201415","volume":"34","author":"WIG Sastra","year":"2022","unstructured":"Sastra WIG, Aditya PPK, Gradiyanto OE, et al. Predictive value of preoperative inflammatory markers and serum CA 125 level for surgical outcome in Indonesian women with epithelial ovarian cancer[J]. Cancer Biomark. 2022;34(1):123\u20139. https:\/\/doi.org\/10.3233\/CBM-201415.","journal-title":"Cancer Biomark"},{"issue":"3","key":"1631_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1053\/j.seminoncol.2014.04.004","volume":"41","author":"AN Davis","year":"2014","unstructured":"Davis AN, Afshar-Kharghan V, Sood AK. Platelet Effects on Ovarian Cancer[J]. Semin Oncol. 2014;41(3):378\u201384. https:\/\/doi.org\/10.1053\/j.seminoncol.2014.04.004.","journal-title":"Semin Oncol"},{"issue":"18","key":"1631_CR27","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1158\/1078-0432.CCR-16-3272","volume":"23","author":"Q Hu","year":"2017","unstructured":"Hu Q, Hisamatsu T, Haemmerle M, et al. Role of Platelet-Derived Tgf\u03b21 in the Progression of Ovarian Cancer[J]. Clin Cancer Res. 2017;23(18):5611\u201321. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3272.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1631_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, et al. Inflammation and tumor progression: signaling pathways and targeted intervention[J]. Signal Transduct Target Ther. 2021;6(1):263. https:\/\/doi.org\/10.1038\/s41392-021-00658-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"1631_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","volume":"33","author":"M Haemmerle","year":"2018","unstructured":"Haemmerle M, Stone RL, Menter DG, et al. The Platelet Lifeline to Cancer: Challenges and Opportunities[J]. Cancer Cell. 2018;33(6):965\u201383. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.002.","journal-title":"Cancer Cell"},{"issue":"7","key":"1631_CR30","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-10-2583","volume":"71","author":"AD Gregory","year":"2011","unstructured":"Gregory AD, McGarry HA. Tumor-Associated Neutrophils: New Targets for Cancer Therapy[J]. Can Res. 2011;71(7):2411\u20136. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2583.","journal-title":"Can Res"},{"issue":"4","key":"1631_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.clbc.2012.04.004","volume":"12","author":"U De Giorgi","year":"2012","unstructured":"De Giorgi U, Mego M, Scarpi E, et al. Relationship Between Lymphocytopenia andCirculating Tumor Cells as Prognostic Factors for Overall Survival in Metastatic Bre ast Cancer[J]. Clin Breast Cancer. 2012;12(4):264\u20139. https:\/\/doi.org\/10.1016\/j.clbc.2012.04.004.","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"1631_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","volume":"265","author":"JCY Chan","year":"2017","unstructured":"Chan JCY, Chan DL, Diakos CI, et al. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer[J]. Ann Surg. 2017;265(3):539\u201346. https:\/\/doi.org\/10.1097\/SLA.0000000000001743.","journal-title":"Ann Surg"},{"issue":"38","key":"1631_CR33","doi-asserted-by":"publisher","first-page":"e21840","DOI":"10.1097\/MD.0000000000021840","volume":"99","author":"Y Dai","year":"2020","unstructured":"Dai Y, Liu M, Lei L, et al. Prognostic significance of preoperative prognostic nutritional index in ovarian cancer[J]. Medicine. 2020;99(38):e21840. https:\/\/doi.org\/10.1097\/MD.0000000000021840.","journal-title":"Medicine"},{"issue":"5","key":"1631_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00520-023-07719-1","volume":"31","author":"J Lee","year":"2023","unstructured":"Lee J, Weng C-S, Chang C-L, et al. Association of prognostic nutritional index with muscle loss and survival in patients with ovarian cancer treated with primary debulking surgery and chemotherapy[J]. Support Care Cancer. 2023;31(5):267. https:\/\/doi.org\/10.1007\/s00520-023-07719-1.","journal-title":"Support Care Cancer"},{"key":"1631_CR35","doi-asserted-by":"publisher","unstructured":"Ding P a, Wu J, Wu H, et al. Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib[J]. BMC Gastroenterology. 2023;23(1):23. https:\/\/doi.org\/10.1186\/s12876-023-02658-x","DOI":"10.1186\/s12876-023-02658-x"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01631-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01631-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01631-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T09:50:55Z","timestamp":1741341055000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01631-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1631"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01631-4","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The collection of patient\u2019s clinical data was approved by the Ethics Committee\u00a0of Linyi People\u2019s Hospital in accordance with the Declaration of Helsinki (202405-H-039). Informed patient consent was not required as the study was retrospective in nature and analyzed patient data anonymously. A statement from the Ethics Committee of Linyi people\u2019s Hospital waived the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors afrm that all participants provided informed consent for publication of the data collected for the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}